$4.16▾ 0.48%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
$-7.30MTTM operating cash
Pre-profit
It is still burning cash while pre-profit.
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
+6.5%year over year
Healthy
Revenue is growing at a steady pace.
Leverage
Not enough data yet
Term-debt data is not available for this company.
More coming: dilution / share-count creep.
✦ The read
Cytek Biosciences, Inc. is pre-profit. It is still burning cash while pre-profit. Revenue is growing at a steady pace.
Key numbers
Profitability
Net margin-36.2%
TTM (trailing 12 months, through fiscal Q1 FY2026)
Size
Revenue (TTM)$204.17M
TTM (trailing 12 months, through fiscal Q1 FY2026)
Signals and key numbers are from the fiscal Q1 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.